These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 22209339)
21. Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data. Brar SS; ten Berg J; Marcucci R; Price MJ; Valgimigli M; Kim HS; Patti G; Breet NJ; DiSciascio G; Cuisset T; Dangas G J Am Coll Cardiol; 2011 Nov; 58(19):1945-54. PubMed ID: 22032704 [TBL] [Abstract][Full Text] [Related]
22. Impact of P-glycoprotein on clopidogrel absorption. Taubert D; von Beckerath N; Grimberg G; Lazar A; Jung N; Goeser T; Kastrati A; Schömig A; Schömig E Clin Pharmacol Ther; 2006 Nov; 80(5):486-501. PubMed ID: 17112805 [TBL] [Abstract][Full Text] [Related]
23. A high maintenance dose of clopidogrel improves short-term clinical outcomes in patients with acute coronary syndrome undergoing drug-eluting stent implantation. Han YL; Wang B; Li Y; Xu K; Wang SL; Jing QM; Wang ZL; Wang DM; Ma YY; Wang G Chin Med J (Engl); 2009 Apr; 122(7):793-7. PubMed ID: 19493391 [TBL] [Abstract][Full Text] [Related]
24. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S; Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956 [TBL] [Abstract][Full Text] [Related]
25. Network meta-analysis of prasugrel, ticagrelor, high- and standard-dose clopidogrel in patients scheduled for percutaneous coronary interventions. Steiner S; Moertl D; Chen L; Coyle D; Wells GA Thromb Haemost; 2012 Aug; 108(2):318-27. PubMed ID: 22627948 [TBL] [Abstract][Full Text] [Related]
26. Association analysis of intractable epilepsy with C3435T and G2677T/A ABCB1 gene polymorphisms in Iranian patients. Sayyah M; Kamgarpour F; Maleki M; Karimipoor M; Gharagozli K; Shamshiri AR Epileptic Disord; 2011 Jun; 13(2):155-65. PubMed ID: 21636342 [TBL] [Abstract][Full Text] [Related]
27. Association of fetal but not maternal P-glycoprotein C3435T polymorphism with fetal growth and birth weight, a possible risk factor for cardiovascular diseases in later life. Li J; Wang ZN; Chen YP; Dong YP; Xiao XM; Hocher B Clin Lab; 2012; 58(9-10):1085-9. PubMed ID: 23163129 [TBL] [Abstract][Full Text] [Related]
28. P-Glycoprotein Polymorphism C3435T Is Associated with Dose-Adjusted Clopidogrel and 2-Oxo-Clopidogrel Concentration. Stokanovic D; Nikolic VN; Konstantinovic SS; Zvezdanovic JB; Lilic J; Apostolovic SR; Pavlovic M; Zivkovic VS; Jevtovic-Stoimenov T; Jankovic SM Pharmacology; 2016; 97(3-4):101-6. PubMed ID: 26695516 [TBL] [Abstract][Full Text] [Related]
29. Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study. Gurbuz AT; Zia AA; Vuran AC; Cui H; Aytac A Eur J Cardiothorac Surg; 2006 Feb; 29(2):190-5. PubMed ID: 16388957 [TBL] [Abstract][Full Text] [Related]
30. High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patients. Tavassoli N; Voisin S; Carrie D; Lapeyre-Mestre M; Galinier M; Montastruc JL; Pathak A Am J Cardiovasc Drugs; 2010; 10(1):29-35. PubMed ID: 20104932 [TBL] [Abstract][Full Text] [Related]
31. Comparison between initial and chronic response to clopidogrel therapy after coronary stenting for acute coronary syndrome and influence on clinical outcomes. Cuisset T; Quilici J; Loosveld M; Gaborit B; Grosdidier C; Fourcade L; Gil JM; Moro PJ; Morange PE; Bonnet JL; Alessi MC Am Heart J; 2012 Sep; 164(3):327-33. PubMed ID: 22980298 [TBL] [Abstract][Full Text] [Related]
32. Association between gene polymorphism and adverse effects in cancer patients receiving docetaxel treatment: a meta-analysis. Yan M; Fan X; Si H; Wang X; Wang Z; Wang Z; Lv X; Yin H; Jia Y; Jiang L; Xia Y; Liu Y Cancer Chemother Pharmacol; 2022 Feb; 89(2):173-181. PubMed ID: 34988655 [TBL] [Abstract][Full Text] [Related]
33. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries. Motovska Z; Kala P Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914 [TBL] [Abstract][Full Text] [Related]
34. C3435T polymorphism of the MDR1 gene is not associated with P-glycoprotein function of leukemic blasts and clinical outcome in patients with acute myeloid leukemia. Hur EH; Lee JH; Lee MJ; Choi SJ; Lee JH; Kang MJ; Seol M; Jang YE; Lee HJ; Kang IS; Shim SK; Ryu SG; Kang YA; Lee YS; Park CJ; Chi HS; Lee KH Leuk Res; 2008 Oct; 32(10):1601-4. PubMed ID: 18272218 [TBL] [Abstract][Full Text] [Related]
35. Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial. Cannon CP; Husted S; Harrington RA; Scirica BM; Emanuelsson H; Peters G; Storey RF; J Am Coll Cardiol; 2007 Nov; 50(19):1844-51. PubMed ID: 17980250 [TBL] [Abstract][Full Text] [Related]
36. Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attack. James SK; Storey RF; Khurmi NS; Husted S; Keltai M; Mahaffey KW; Maya J; Morais J; Lopes RD; Nicolau JC; Pais P; Raev D; Lopez-Sendon JL; Stevens SR; Becker RC; Circulation; 2012 Jun; 125(23):2914-21. PubMed ID: 22572911 [TBL] [Abstract][Full Text] [Related]
37. Association between the MDR1 gene variant C3435T and risk of leukaemia: a meta-analysis. Zhang BB; Xuan C; Deng KF; Wu N; Lun LM Eur J Cancer Care (Engl); 2013 Sep; 22(5):617-25. PubMed ID: 23731124 [TBL] [Abstract][Full Text] [Related]
38. P2Y12 Polymorphisms and the Risk of Adverse Clinical Events in Patients Treated with Clopidogrel: A Meta-Analysis. Zhao K; Yang M; Lu Y; Sun S; Li W; Li X; Zhao Z Drug Res (Stuttg); 2019 Jan; 69(1):23-31. PubMed ID: 29791922 [TBL] [Abstract][Full Text] [Related]
39. The Effect of the ABCB1(MDR-1) C3435T Polymorphism in Turkish Patients with Aspirin Resistance in Acute Ischemic Stroke. Yurek E; Yavuz BG; Tanoglu EG; Gurkas E; Altundag I; Yalcinkaya B; Yılmaz E; Colak S Transl Stroke Res; 2024 Oct; 15(5):910-915. PubMed ID: 37432593 [TBL] [Abstract][Full Text] [Related]
40. ABCB1 C3435T and CYP2C19*2 polymorphisms in a Palestinian and Turkish population: A pharmacogenetic perspective to clopidogrel. Nassar S; Amro O; Abu-Rmaileh H; Alshaer I; Korachi M; Ayesh S Meta Gene; 2014 Dec; 2():314-9. PubMed ID: 25606414 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]